DE3686275D1 - Praeparate mit verzoegerter freisetzung. - Google Patents

Praeparate mit verzoegerter freisetzung.

Info

Publication number
DE3686275D1
DE3686275D1 DE8686300039T DE3686275T DE3686275D1 DE 3686275 D1 DE3686275 D1 DE 3686275D1 DE 8686300039 T DE8686300039 T DE 8686300039T DE 3686275 T DE3686275 T DE 3686275T DE 3686275 D1 DE3686275 D1 DE 3686275D1
Authority
DE
Germany
Prior art keywords
delayed release
prepared products
products
prepared
delayed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686300039T
Other languages
English (en)
Other versions
DE3686275T2 (de
Inventor
Yuji Makino
Hideo Matugi
Yoshiki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP216085A external-priority patent/JPS61161216A/ja
Priority claimed from JP11969285A external-priority patent/JPS61277634A/ja
Priority claimed from JP13592085A external-priority patent/JPS61293931A/ja
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DE3686275D1 publication Critical patent/DE3686275D1/de
Publication of DE3686275T2 publication Critical patent/DE3686275T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8686300039T 1985-01-11 1986-01-06 Praeparate mit verzoegerter freisetzung. Expired - Fee Related DE3686275T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP216085A JPS61161216A (ja) 1985-01-11 1985-01-11 キトサン類を用いた徐放性医薬品組成物
JP11969285A JPS61277634A (ja) 1985-06-04 1985-06-04 徐放性医薬品組成物
JP13592085A JPS61293931A (ja) 1985-06-24 1985-06-24 徐放性医薬品組成物

Publications (2)

Publication Number Publication Date
DE3686275D1 true DE3686275D1 (de) 1992-09-10
DE3686275T2 DE3686275T2 (de) 1993-03-18

Family

ID=27275226

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686300039T Expired - Fee Related DE3686275T2 (de) 1985-01-11 1986-01-06 Praeparate mit verzoegerter freisetzung.

Country Status (3)

Country Link
US (1) US4814176A (de)
EP (1) EP0187703B1 (de)
DE (1) DE3686275T2 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US5264422A (en) * 1986-06-30 1993-11-23 Fidia S.P.A. Esters of alginic acid with steroidal alcohols
US5147861A (en) * 1986-06-30 1992-09-15 Fidia S.P.A. Esters of alginic acid
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IT1229856B (it) * 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
JPH064531B2 (ja) * 1990-06-04 1994-01-19 アイセロ化学株式会社 大腸崩壊性硬質カプセル
ATE104154T1 (de) * 1990-07-26 1994-04-15 Searle & Co Arzneimittel freisetzendes polymeres system.
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US5213887A (en) * 1991-09-03 1993-05-25 Minnesota Mining And Manufacturing Company Antistatic coatings
US6136793A (en) * 1992-02-20 2000-10-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
US6114314A (en) * 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
FR2694894B1 (fr) * 1992-08-20 1994-11-10 Coletica Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une substance polyaminée ou polyhydroxylée pour la fabrication de microparticules, procédé et composition.
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
CA2146547A1 (en) * 1993-08-06 1995-02-16 William J. Embro Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
US5518736A (en) * 1994-06-27 1996-05-21 Yissum Research Development Company Of The Hebrew Method of preparing natural-oil-containing emulsions and microcapsules and its uses
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
GB2328443B (en) 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
NZ504160A (en) 1997-10-03 2001-08-31 Lavipharm Lab Inc A prolamine-plant polar lipid composition, its method of preparation and applications thereof
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
CA2389235C (en) 1999-10-29 2007-07-17 Euro-Celtique, S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2283829A1 (de) 2000-10-30 2011-02-16 Euro-Celtique S.A. Hydrocodon-Formulierungen mit gesteuerter Freisetzung
US20020176841A1 (en) * 2001-03-19 2002-11-28 Praecis Pharmaceuticals Inc. Pharmaceutical formulations for sustained release
US20060198815A1 (en) * 2001-03-19 2006-09-07 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained release
KR20030006788A (ko) * 2001-07-16 2003-01-23 이승진 치주질환 치료용 서방출성 고분자제제
US20040091528A1 (en) * 2002-11-12 2004-05-13 Yamanouchi Pharma Technologies, Inc. Soluble drug extended release system
US20040219210A1 (en) * 2003-05-01 2004-11-04 Jian-Hwa Guo Controlled release solid dosage nifedipine formulations
DE60319983T2 (de) * 2003-09-01 2009-07-23 Jpm - The Jordanian Pharmaceutical Manufacturing Co. Ltd. Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan
US20050085443A1 (en) * 2003-09-19 2005-04-21 Pavinee Chinachoti Composition and method for treating bezoar and trichobezoar
EP1586313A1 (de) * 2004-04-07 2005-10-19 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Metoclopramid enthaltende pharmazeutische Zubereitungen und Herstellungsmethode
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
ES2284088T3 (es) * 2005-01-19 2007-11-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composicion farmaceutica polimerica de liberacion controlada oral para administracion de sulfatos de terbutalina.
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
EP2063859B1 (de) * 2006-09-13 2017-01-18 Enhance Skin Products Inc. Kosmetische zusammensetzung zur behandlung der haut und verfahren dafür
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
FR2936952A1 (fr) * 2008-10-09 2010-04-16 Monique Bellec Administration par voie orale de medicaments et complements nutritionnels
WO2010084397A2 (en) 2009-01-20 2010-07-29 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
MX2012012991A (es) 2010-05-11 2012-11-30 Cima Labs Inc Formas de dosificacion oral de liberacion prolongada resistentes al alcohol y que contienen metoprolol.
CA2821805A1 (en) * 2010-12-16 2012-06-21 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
US9532977B2 (en) 2010-12-16 2017-01-03 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
EP2699099A1 (de) * 2011-04-20 2014-02-26 Gumlink A/S Kaugummi mit chitosan zur verringerung des gehalts an freien phosphorverbindungen im verdauungssaft
CN112370437B (zh) * 2020-10-20 2022-10-21 好医生药业集团有限公司 一种阿莫西林胶囊及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
US4301067A (en) * 1979-06-05 1981-11-17 Kureha Kagaku Kogyo Kabushiki Kaisha Chitin containing poly-ion complex
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US4501835A (en) * 1982-03-08 1985-02-26 Polaroid Corporation Polyacrylic acid/chitosan polyelectrolyte complex
DK171716B1 (da) * 1982-03-12 1997-04-07 Pharmacia & Upjohn Ab Fremgangsmåde til fremstilling af et kompleks af carrageenan og emepronium, doxycyklin eller propranolol
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation

Also Published As

Publication number Publication date
EP0187703A3 (en) 1987-05-20
US4814176A (en) 1989-03-21
DE3686275T2 (de) 1993-03-18
EP0187703B1 (de) 1992-08-05
EP0187703A2 (de) 1986-07-16

Similar Documents

Publication Publication Date Title
DE3686275D1 (de) Praeparate mit verzoegerter freisetzung.
DE3775483D1 (de) Zubereitung mit verzoegerter freigabe.
DE3684446D1 (de) Arzneimittel mit verzoegerter stossweiser freisetzung.
DE3782840D1 (de) Arzneimittel mit verzoegerter freigabe.
DE3778106D1 (de) Dosierungsform mit verzoegernder freisetzung.
DE3683144D1 (de) Pflaster mit verzoegerter abgabe.
DE3685877D1 (de) Heizoelprodukte.
DE3786247D1 (de) Lanzette mit rueckfuehrung.
DE3680982D1 (de) Mikrowellen ausgesetzte lebensmittelverpackung.
FI865379A0 (fi) Belysningsanordning med variabel ljuspunkt foersedd med konstant konvergeringsvinkel.
NO861696L (no) Kopling.
DE69003568D1 (de) Arzneimittel mit verzoegerter freigabe.
DE3882739D1 (de) Matrix-zubereitungen mit verzoegerter freisetzung.
DE3684719D1 (de) Mit einpraegungen versehene gegenstaenden.
ATE44213T1 (de) Beschichtetes nahrungsmittel.
DE68913323D1 (de) Antischaum-Zusatzstoffe mit verzögerter Freisetzung.
DE3681620D1 (de) Kochgeraet.
DE3882344D1 (de) Nahrungsmittel.
FR2586768B1 (fr) Embrayage.
DE3686698D1 (de) Futterzusammensetzung.
DE68904569D1 (de) Nahrungsmittel.
DE3782439D1 (de) Dihydropyridin-formulierung mit verzoegerter freigabe.
DE3868866D1 (de) Ergolinderivate mit antiparkinsonwirkung.
DE3676679D1 (de) Verpacken.
FI862717A0 (fi) Foerbaettrat kollagenkorvskal.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee